Rothstein B. Topical JAK inhibitor Ruxolitinib for Vitiligo Treatment. J of Skin [Internet]. 2018Dec.17 [cited 2024Sep.20];2:S110-S111. Available from: https://dermsquared.com/skin/article/view/451